/THC
Tenet Healthcare Corporation
THC • NYSETHC • NYSE • Healthcare
$207.27-2.06%-4.37
$207.27-2.06%(-4.37)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
64Low Risk
Momentum
55Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
41.4%▲1.7pp
Revenue after COGS
Operating
16.5%▼12.4pp
After operating expenses
Net
6.6%▼8.9pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
12.8
Price vs earnings
EV/EBITDA
6.6
Enterprise value
FCF Yield
14.0%
Cash generation
Earnings Yield
7.8%
Inverse of P/E
Capital Efficiency
17
GoAI Quality ScoreStrong
ROEReturn on Equity
33.3%Strong
ROAReturn on Assets
4.7%Fair
ROICReturn on Invested Capital
11.7%Strong
Financial Health
Current RatioHealthy
1.76
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
2.39x
Debt repayment capacity (<3x)
Income QualityStrong
2.52
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $21.31B | $20.66B | $20.55B | $19.17B | $19.48B |
| Gross Profit | $8.82B | $8.21B | $7.80B | $7.05B | $7.27B |
| Gross Margin | 41.4% | 39.7% | 38.0% | 36.8% | 37.3% |
| Operating Income | $3.51B | $5.96B | $2.51B | $2.33B | $2.87B |
| Net Income | $1.41B | $3.20B | $611.00M | $411.00M | $914.00M |
| Net Margin | 6.6% | 15.5% | 3.0% | 2.1% | 4.7% |
| EPS | $15.61 | $33.02 | $6.01 | $3.84 | $8.55 |
Average Price Target
$258.55▲ 24.7% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Tenet Healthcare Corporation, the average price target is $258.55, with a high forecast of $288.00 and a low forecast of $224.00. The average price target represents a 24.7% increase from the current price of $207.27.
Highest
$288.00
Average
$258.55
Lowest
$224.00
Rating Distribution
Strong Buy
0
0%
Buy
25
78%
Hold
7
22%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Guggenheim● Maintain
Buy
2026-03-12Mizuho● Maintain
Outperform
2026-03-12Leerink Partners● Maintain
Outperform
2026-02-20Truist Securities● Maintain
Buy
2026-02-17Guggenheim● Maintain
Buy
2026-02-13Barclays● Maintain
Overweight
2026-02-13Keybanc● Maintain
Overweight
2026-02-12Jefferies● Maintain
Buy
2026-02-12UBS● Maintain
Buy
2026-02-12RBC Capital● Maintain
Outperform
2026-02-12Earnings History & Surprises
BEAT RATE
100%
Last 18 quarters
AVG SURPRISE
+46.0%
EPS vs Estimate
BEATS / MISSES
18/0
Last 18 quarters
LATEST EPS
$4.70
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+15.5%
$4.70 vs $4.07
Q4 '25
+10.8%
$3.70 vs $3.34
Q3 '25
+40.1%
$4.02 vs $2.87
Q2 '25
+39.7%
$4.36 vs $3.12
Q1 '25
+16.6%
$3.44 vs $2.95
Q4 '24
+25.8%
$2.93 vs $2.33
Q3 '24
+21.6%
$2.31 vs $1.90
Q2 '24
+122.1%
$3.22 vs $1.45
Q1 '24
+67.5%
$2.68 vs $1.60
Q4 '23
+20.0%
$1.44 vs $1.20
Q3 '23
+15.2%
$1.44 vs $1.25
Q2 '23
+22.4%
$1.42 vs $1.16
No investor questions available.
Latest News
No news available